who makes the glp 1 drugs GLP-1 are often misunderstood. They are not “celebrity weight loss injections.” They are result of 40 years of metabolic research and may change how we treat obesity, diabetes, and aging Market Overview: GLP-1 Agonists and

[19] [20] The FDA approved it for weight loss in November 2023

In diabetic mice, semaglutide alleviated anxiety- and depression-like behaviors and improved cognitive performance via modulation of the microbiota-gut-brain axis ( In summary, accumulating evidence supports the potential of GLP-1RAs in treating neurodegenerative and psychosocial disorders

In February, researchers from the University of Leicester and the Leicester Diabetes Centre published a review article on obesity in the "International Journal of Obesity," introducing the current and future drug development pipeline for the treatment of obesity, with special attention given to novel therapies based on the mechanisms of gut incretin hormones

Instead, it contains ingredients that have been studied for potential effects on GLP-1 levels, appetite, blood sugar, and body composition

J Hypertens 2021;39:10907

Sanders didnt hold back: Treat the American people the same way that you treat people all over the world